Arcadia Biosciences CEO Matthew Plavan's 2019 pay stays at $581K
Arcadia Biosciences reports 2019 executive compensation
By ExecPay News
Published: April 17, 2020
Arcadia Biosciences reported fiscal year 2019 executive compensation information on April 17, 2020.
In 2019, five executives at Arcadia Biosciences received on average a compensation package of $445K, a 29% decrease compared to previous year.
Average pay of disclosed executives at Arcadia Biosciences
Matthew Plavan, Chief Executive Officer, received $581K in total, which is about the same as previous year. 55% of Plavan's compensation, or $322K, was in salary. Plavan also received $155K in non-equity incentive plan and $105K in option awards.
Rajendra Ketkar, Chief Executive Officer, received a compensation package of $562K, which decreased by 38% compared to previous year. 47% of the compensation package, or $264K, was in salary.
Sarah Reiter, Chief Commercial Officer, earned $456K in 2019, a 42% decrease compared to previous year.
Randall Shultz, Chief Technology Officer, received $340K in 2019.
Pamela Haley, Chief Financial Officer, earned $285K in 2019, a 22% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 17, 2020.